Annual report for Zim Laboratories Ltd. for FY-2023
19-05-2023
Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that Q4 and FY 23 Earnings Conference Call is scheduled to be held on Monday, 22nd May, 2023 at 12:00 p.m. IST.17-05-2023
Zim Laboratories Ltd - 541400 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 ,inter alia, to consider and approve a) consider and approve the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2023. b) consider and approve the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2023 (prepared pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015). In connection with the above, as per SEBI (Prohibition of Insider Trading) Regulation, 2015 and Company's Code of Conduct to Regulate, Monitor and Report of Trading by Insiders, the trading window for dealing with securities of the Company is closed from Saturday 01st April, 2023 to Sunday the 21st May, 2023 (both days inclusive).10-05-2023
Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificate received from Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company against the request from shareholder for issue of duplicate share certificate and accordingly, RTA has marked stop transfer until Duplicate Share Certificate is issued.03-05-2023
Zim Laboratories Ltd - 541400 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyZim Laboratories Ltd 2CIN NO.L99999MH1984PLC032172 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 59.30 4Highest Credit Rating during the previous FY BBB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ACUITE RATINGS & RESEARCH LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Piyush Nikhade Designation: Company Secretary and Compliance Officer EmailId: cs@zimlab.in Name of the Chief Financial Officer: Shyam Mohan Patro Designation: Chief Financial Officer EmailId: shyam.patro@zimlab.in Date: 28/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.28-04-2023
Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the requests received from shareholders, the Company has issued Duplicate Share Certificates in place of Share Certificate lost / misplaced etc. by the said shareholders.28-04-2023
Zim Laboratories Ltd - 541400 - Clarification On News Items Appearing In Various Media/Publications
With reference to certain recently published News Articles, we would like to provide the following clarifications to avoid information disparity in public at large: We would like to inform that the company has neither received any show-cause notice nor any notice to stop manufacturing from any Drug Authority including DCGI or local drug authority as mentioned in the News Articles. ZIM Laboratories Limited adheres to current Good Manufacturing Practices as applicable and is accredited by Regulatory Authorities for marketing and distribution of several products in India and abroad. The Company is conscious of its disclosure obligations under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and will make disclosures if and when the same is required under the Listing Regulations. We request you to take the above on record.21-04-2023
Zim Laboratories Ltd - 541400 - Clarification On News Items Appearing In Various Media/Publications
With reference to certain recently published News Articles, we would like to provide the following clarifications to avoid information disparity in public at large: We would like to inform that the company has neither received any show-cause notice nor any notice to stop manufacturing from any Drug Authority including DCGI or local drug authority as mentioned in the News Articles. ZIM Laboratories Limited adheres to current Good Manufacturing Practices as applicable and is accredited by Regulatory Authorities for marketing and distribution of several products in India and abroad. The Company is conscious of its disclosure obligations under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and will make disclosures if and when the same is required under the Listing Regulations. We request you to take the above on record.21-04-2023
Zim Laboratories Ltd - 541400 - Submission Of Certificate Issued Under Regulation 40(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 40(10) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed Certificate dt. 19.04.2023 for year ended March 31, 2023 issued under Regulation 40(9) by Practicing Company Secretaries - Mehta & Mehta, Mumbai.20-04-2023
Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the request received from shareholder, the Company has issued Duplicate Share Certificate in place of Share Certificate lost / misplaced etc. by the said shareholder.20-04-2023